Zhao YN - Search Results

1

[Evaluation of the risk of clonorchiasis inducing primary hepatocellular carcinoma].

Tan SK, Qiu XQ, Yu HP, Zeng XY, Zhao YN, Hu L. Tan SK, et al. Among authors: zhao yn. Zhonghua Gan Zang Bing Za Zhi. 2008 Feb;16(2):114-6. Zhonghua Gan Zang Bing Za Zhi. 2008. PMID: 18304427 Chinese.

2

[Surgery-predominant comprehensive therapy for 134 patients with small hepatocellular carcinoma].

Mo QG, Liang AM, Yang NW, Zhao YN, Yuan WP. Mo QG, et al. Among authors: zhao yn. Ai Zheng. 2003 Feb;22(2):189-91. Ai Zheng. 2003. PMID: 12600298 Chinese.

3

[Expression and significance of EGF mRNA and EGFR mRNA in hepatocellular carcinoma].

Zhao YN, Cao J, Wu FX, Ou C, Yuan WP, Mo QG, Wei W, Li Y, Su JJ, Liang AM. Zhao YN, et al. Ai Zheng. 2004 Jul;23(7):762-6. Ai Zheng. 2004. PMID: 15248908 Chinese.

4

[Expression and significance of epidermal growth factor receptor variant type III in hepatocellular carcinoma].

Ou C, Wu FX, Luo Y, Cao J, Zhao YN, Yuan WP, Li Y, Su JJ. Ou C, et al. Among authors: zhao yn. Ai Zheng. 2005 Feb;24(2):166-9. Ai Zheng. 2005. PMID: 15694026 Chinese.

5

[Expression and significance of erb-B receptor family in hepatocellular carcinoma].

Cao J, Zhao YN, Wu FX, Ou C, Ban KC, Wei W, Li Y, Su JJ, Liang AM. Cao J, et al. Among authors: zhao yn. Zhonghua Gan Zang Bing Za Zhi. 2005 Feb;13(2):146-7. Zhonghua Gan Zang Bing Za Zhi. 2005. PMID: 15727712 Chinese. No abstract available.

6

Development and validation of an RNA binding protein-associated prognostic model for hepatocellular carcinoma.

Wang M, Huang S, Chen Z, Han Z, Li K, Chen C, Wu G, Zhao Y. Wang M, et al. BMC Cancer. 2020 Nov 23;20(1):1136. doi: 10.1186/s12885-020-07625-3. BMC Cancer. 2020. PMID: 33228611 Free PMC article.

7

Identifying serological biomarkers of hepatocellular carcinoma using surface-enhanced laser desorption/ionization-time-of-flight mass spectroscopy.

Wu FX, Wang Q, Zhang ZM, Huang S, Yuan WP, Liu JY, Ban KC, Zhao YN. Wu FX, et al. Among authors: zhao yn. Cancer Lett. 2009 Jul 8;279(2):163-70. doi: 10.1016/j.canlet.2009.01.034. Epub 2009 Mar 5. Cancer Lett. 2009. PMID: 19268439

8

Treatment efficacy and prognostic factors for huge HCC based on Barcelona Clinic Liver Cancer staging.

Zhang ZM, Zhang YM, Gao S, Yuan WP, Zhao YN, Xiang BD, Wu FX, Wu GB, Liu JY. Zhang ZM, et al. Among authors: zhao yn. Asian Pac J Cancer Prev. 2014;15(20):8823-8. doi: 10.7314/apjcp.2014.15.20.8823. Asian Pac J Cancer Prev. 2014. PMID: 25374214 Free article.

9

miR-128-3p suppresses hepatocellular carcinoma proliferation by regulating PIK3R1 and is correlated with the prognosis of HCC patients.

Huang CY, Huang XP, Zhu JY, Chen ZG, Li XJ, Zhang XH, Huang S, He JB, Lian F, Zhao YN, Wu GB. Huang CY, et al. Among authors: zhao yn. Oncol Rep. 2015 Jun;33(6):2889-98. doi: 10.3892/or.2015.3936. Epub 2015 Apr 28. Oncol Rep. 2015. PMID: 25962360

10

Hepatic resection versus transarterial chemoembolization for patients with Barcelona Clinic Liver Cancer intermediate stage Child-Pugh A hepatocellular carcinoma.

Zhao YN, Zhang YQ, Ye JZ, Liu X, Yang HZ, Cong FY, Xiang BD, Wu FX, Ma L, Li LQ, Ye HH. Zhao YN, et al. Exp Ther Med. 2016 Dec;12(6):3813-3819. doi: 10.3892/etm.2016.3810. Epub 2016 Oct 17. Exp Ther Med. 2016. PMID: 28105115 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

357 results

Search Page

Filters